![Steven Gourlay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Gourlay
Verkställande Direktör på
ACTINOGEN MEDICAL LIMITED
Förmögenhet: 4 M $ per 2026-06-30
Profil
Dr. Steven G.
Gourlay is a Chief Executive Officer, MD & Director at Actinogen Medical Ltd. He is on the Board of Directors at Actinogen Medical Ltd. Dr. Gourlay was previously employed as a Chief Medical Officer by Principia Biopharma, Inc., a Partner by GBS Venture Partners Pty Ltd., a Senior Director-Clinical & Safety by Genentech, Inc., a Faculty Member by Monash University, and a Non-Executive Director by Verva Pharmaceuticals Ltd. He also served on the board at Applied Physiology Pty Ltd., Elastagen Pty Ltd. and Endoluminal Sciences Pty Ltd. He received his undergraduate degree from the University of Melbourne, an MBA from Macquarie University, a doctorate degree from The University of California, San Francisco and a doctorate degree from Monash University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-24 | 203 275 557 ( 5,55 % ) | 4 M $ | 2026-06-30 |
Aktiva positioner av Steven Gourlay
| Företag | Position | Start |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Verkställande Direktör | 2021-03-15 |
Tidigare kända positioner av Steven Gourlay
| Företag | Position | Slut |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-10-24 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2004-01-01 |
Verva Pharmaceuticals Ltd.
 Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies to treat diabetes | Direktör/Styrelseledamot | - |
Endoluminal Sciences Pty Ltd.
 Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Develops novel platform technologies for endovascular prostheses | Direktör/Styrelseledamot | - |
Elastagen Pty Ltd.
 Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Produces and develops synthetic human elastin for medical device applications | Direktör/Styrelseledamot | - |
Steven Gourlays utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
86
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partner seeks investment opportunities in private and public companies located in the United States, New Zealand and primarily in Australia. The firm targets companies operating in the fields of human healthcare, biotechnology, life science, biological/small molecule therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements with an investment size ranging from of USD 10 to 12 million. It takes an active role on the board of directors and acts as a lead investor. It also makes co-investments. | Finance |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Applied Physiology Pty Ltd.
 Applied Physiology Pty Ltd. Medical DistributorsDistribution Services Develops therapeutic guidance systems for the critical care markets | Distribution Services |
Verva Pharmaceuticals Ltd.
Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies to treat diabetes | Health Technology |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Produces and develops synthetic human elastin for medical device applications | Health Technology |
Endoluminal Sciences Pty Ltd.
Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Develops novel platform technologies for endovascular prostheses | Distribution Services |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
